

| Biological Activity | |||||||||||||||||||||||||
| Synonyms | GSK-923295 | ||||||||||||||||||||||||
| Chemical Name | 3-chloro-N-[(2S)-1-[[2-(dimethylamino)acetyl]amino]-3-[4-[8-[(1S)-1-hydroxyethyl]imidazo[1,2-a]pyridin-2-yl]phenyl]propan-2-yl]-4-propan-2-yloxybenzamide | ||||||||||||||||||||||||
| Application | GSK 923295 is a specific allosteric inhibitor of CENP-E kinesin motor ATPase | ||||||||||||||||||||||||
| CAS Number | 1088965-37-0 | ||||||||||||||||||||||||
| Purity | ≥99.0% | ||||||||||||||||||||||||
| Molecular Weight | 592.13 | ||||||||||||||||||||||||
| Molecular Formula | C₃₂H₃₈ClN₅O₄ | ||||||||||||||||||||||||
| SMILES | C[C@@H](C1=CC=CN2C1=NC(=C2)C3=CC=C(C=C3)C[C@@H](CNC(=O)CN(C)C)NC(=O)C4=CC(=C(C=C4)OC(C)C)Cl)O | ||||||||||||||||||||||||
| Target & IC50 | CENP-E | ||||||||||||||||||||||||
| Shipping | Gel Pack | ||||||||||||||||||||||||
| Storage | Store at -20°C | ||||||||||||||||||||||||
|
|||||||||||||||||||||||||
| Solubility | |
| DMSO: 100 mg/mL (168.88 mM)
Ethanol: 100 mg/mL (168.88 mM) |
| Product Description | |
GSK 923295 is a potent and selective mitotic kinesin Centromere protein E (CENP-E) inhibitor, a protein that accumulates in the G2 phase of the cell cycle. It is proposed to be one of the motors responsible for mammalian chromosome movement and spindle elongation. GSK923295 induces mitotic arrest and chromosome alignment failure. It is reported to be a potent inhibitor of tumor cell growth, which is further enhanced when MEK/ERK signaling is also inhibited. |